M&As looming larger in pharmaceutical industry

Published: 2011-11-17 06:58:00

Updated: 2011-11-17 06:58:00

The government’s plan to cut domestic drug prices by an average of 14 percent will make it harder for companies to do business in the pharmaceutical market.

Analysts expect a large number of mergers and acquisitions (M&A) to take place among pharmaceutical companies, and restructuring seems in...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK